THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,630 | -16.6% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $10,350 | -52.3% | 1,000 | -50.0% | 0.01% | -58.3% |
| Q1 2023 | $21,700 | -3.3% | 2,000 | 0.0% | 0.01% | -7.7% |
| Q4 2022 | $22,440 | +12.2% | 2,000 | 0.0% | 0.01% | +8.3% |
| Q3 2022 | $20,000 | +11.1% | 2,000 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $18,000 | -5.3% | 2,000 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $19,000 | -13.6% | 2,000 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $22,000 | +46.7% | 2,000 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $15,000 | -48.3% | 2,000 | 0.0% | 0.01% | -50.0% |
| Q2 2021 | $29,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |